Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jun 1;90(11):2053-8.
doi: 10.1038/sj.bjc.6601705.

Role of infiltrated leucocytes in tumour growth and spread

Affiliations
Review

Role of infiltrated leucocytes in tumour growth and spread

E Y Lin et al. Br J Cancer. .

Abstract

Leucocytes are a major component of the tumour microenvironment. Recent studies have indicated that the infiltration and activity of these host cells are regulated by the tumour to promote its survival and progression. Through the production of an array of growth factors, proteases and angiogenic mediators, leucocytes in the tumour microenvironment promote tumour growth, angiogenesis and metastasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Leucocytic infiltration promotes tumour progression to malignancy. In a manner similar to wounded tissues, solid tumours induce a local ‘inflammatory response’ by attracting leucocytes into its microenvironment. Such an infiltration consists of multiple cell types of which cells of the myeloid lineage are the major component. Leucocytes in such ‘inflammatory sites’ produce an array of growth and angiogenic factors, proteases and mutagenic factors that promote tumour growth, invasion and angiogenesis. However, different from its physiological counterpart whose inflammation ceases when the wound has healed, tumour-induced inflammation persists and eventually leads to tumour progression and metastasis.

Similar articles

Cited by

References

    1. Aharinejad S, Abraham D, Paulus P, Abri H, Hofmann M, Grossschmidt K, Schafer R, Stanley ER, Hofbauer R (2002) Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res 62: 5317–5324 - PubMed
    1. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI (2000) Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6: 1755–1766 - PubMed
    1. Amann B, Perabo FG, Wirger A, Hugenschmidt H, Schultze-Seemann W (1998) Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer. Br J Urol 82: 118–121 - PubMed
    1. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Strom SR, Burdick MD, lannettoni MD, Strieter RM (2000) Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother 49: 63–70 - PMC - PubMed
    1. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539–545 - PubMed

MeSH terms